Print Page     Close Window     

SEC Filings

424B3
BIOTIME INC filed this Form 424B3 on 02/04/2019
Entire Document
 
 

 

INDEX TO ASTERIAS FINANCIAL STATEMENTS

 

Report of OUM & CO. LLP, Independent Registered Public Accounting Firm   F-2
Balance Sheets as of December 31, 2017 and December 31, 2016   F-3
Statements of Operations for the fiscal years ended December 31, 2017, December 31, 2016 and December 31, 2015   F-4
Statements of Comprehensive Loss for the fiscal years ended December 31, 2017, December 31, 2016 and December 31, 2015   F-5
Statements of Stockholders Equity for the Fiscal Years Ended December 31, 2017, December 31, 2016 and December 31, 2015   F-6
Statements of Cash Flows for the fiscal years ended December 31, 2017, December 31, 2016 and December 31, 2015   F-7
Notes to Financial Statements   F-8
Condensed Balance Sheets (unaudited) as of September 30, 2018 and December 31, 2017   F-32
Condensed Statements of Operations (unaudited) for the three and nine months ended September 30, 2018 and September 30, 2017   F-33
Condensed Statements of Comprehensive Loss (unaudited) for the three and nine months ended September 30, 2018 and September 30, 2017   F-34
Condensed Statements of Cash Flows (unaudited) for the nine months ended September 30, 2018 and September 30, 2017   F-35
Notes to Condensed Financial Statements (unaudited)   F-36

 

 F-1 

© Copyright BioTime, Inc.